• share
• favorite_border

A study led by Roswell Park provides new insight into the complex interactions of the 鈥渢umor-immune-gut axis,鈥� and its role in influencing immunotherapy responses in patients with recurrent ovarian cancer. Newly published in Nature Communications, the findings emphasize the role of the patient鈥檚 microbiome 鈥� the collection of microorganisms in the body 鈥攁nd lay the groundwork for future clinical trials aimed at improving treatment outcomes.